Cargando…
Antagonistic control of active surface integrins by myotubularin and phosphatidylinositol 3-kinase C2β in a myotubular myopathy model
X-linked centronuclear myopathy (XLCNM) is a severe human disease without existing therapies caused by mutations in the phosphoinositide 3-phosphatase MTM1. Loss of MTM1 function is associated with muscle fiber defects characterized by impaired localization of β-integrins and other components of foc...
Autores principales: | Samsó, Paula, Koch, Philipp A., Posor, York, Lo, Wen-Ting, Belabed, Hassane, Nazare, Marc, Laporte, Jocelyn, Haucke, Volker |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549396/ https://www.ncbi.nlm.nih.gov/pubmed/36161941 http://dx.doi.org/10.1073/pnas.2202236119 |
Ejemplares similares
-
Loss of Myotubularin Function Results in T-Tubule Disorganization in Zebrafish and Human Myotubular Myopathy
por: Dowling, James J., et al.
Publicado: (2009) -
Centronuclear (myotubular) myopathy
por: Jungbluth, Heinz, et al.
Publicado: (2008) -
Extensive morphological and immunohistochemical characterization in myotubular myopathy
por: Shichiji, Minobu, et al.
Publicado: (2013) -
Tamoxifen therapy in a murine model of myotubular myopathy
por: Maani, Nika, et al.
Publicado: (2018) -
Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances
por: Gómez-Oca, Raquel, et al.
Publicado: (2021)